Rykindo (risperidone extended release microspheres) / Luye Group  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rykindo (risperidone extended release microspheres) / Luye Group
2016-005010-22: not applicable

Ongoing
3
250
RoW
LY03004, RISPERDAL® CONSTA®, TEST, REFERENCE, Powder and solvent for prolonged-release suspension for injection, EU Risperdal® Consta®
Nanjing Luye Pharmaceutical Co., Ltd., Nanjing Luye Pharmaceutical Co., Ltd., Luye Pharma Group, Ltd.
schizophrenia, schizophrenia, Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 

Download Options